APA

Balasubramanian B. N., St Laurent D. R., Saulnier M. G., Long B. H., Bachand C., Beaulieu F., Clarke W., Deshpande M., Eummer J., Fairchild C. R., Frennesson D. B., Kramer R., Lee F. Y., Mahler M., Martel A., Naidu B. N., Rose W. C., Russell J., Ruediger E., Solomon C., Stoffan K. M., Wong H., Wright J. J., Zimmermann K. & Vyas D. M. (20040510). Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model. : Journal of medicinal chemistry.

Chicago

Balasubramanian Balu N, St Laurent Denis R, Saulnier Mark G, Long Byron H, Bachand Carol, Beaulieu Francis, Clarke Wendy, Deshpande Milind, Eummer Jeffrey, Fairchild Craig R, Frennesson David B, Kramer Robert, Lee Frank Y, Mahler Mikael, Martel Alain, Naidu B Narasimhulu, Rose William C, Russell John, Ruediger Edward, Solomon Carola, Stoffan Karen M, Wong Henry, Wright John J, Zimmermann Kurt and Vyas Dolatrai M. 20040510. Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model. : Journal of medicinal chemistry.

Harvard

Balasubramanian B. N., St Laurent D. R., Saulnier M. G., Long B. H., Bachand C., Beaulieu F., Clarke W., Deshpande M., Eummer J., Fairchild C. R., Frennesson D. B., Kramer R., Lee F. Y., Mahler M., Martel A., Naidu B. N., Rose W. C., Russell J., Ruediger E., Solomon C., Stoffan K. M., Wong H., Wright J. J., Zimmermann K. and Vyas D. M. (20040510). Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model. : Journal of medicinal chemistry.

MLA

Balasubramanian Balu N, St Laurent Denis R, Saulnier Mark G, Long Byron H, Bachand Carol, Beaulieu Francis, Clarke Wendy, Deshpande Milind, Eummer Jeffrey, Fairchild Craig R, Frennesson David B, Kramer Robert, Lee Frank Y, Mahler Mikael, Martel Alain, Naidu B Narasimhulu, Rose William C, Russell John, Ruediger Edward, Solomon Carola, Stoffan Karen M, Wong Henry, Wright John J, Zimmermann Kurt and Vyas Dolatrai M. Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model. : Journal of medicinal chemistry. 20040510.